Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RGEN Repligen Corporation

盘前交易 05-02 04:32:55 EDT

158.36

-5.84

-3.56%

最高164.15	最低151.82	成交量90.93万
今开159.00	昨收164.20	日振幅7.51%
总市值88.43亿	流通市值82.37亿	总股本5,584万
成交额1.44亿	换手率1.75%	流通股本5,201万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"RGEN","market":"US","secType":"STK","nameCN":"Repligen Corporation","latestPrice":158.36,"timestamp":1714593600000,"preClose":164.2,"halted":0,"volume":909296,"delay":0,"floatShares":52013199,"shares":55838548,"eps":0.74,"marketStatus":"盘前交易","marketStatusCode":1,"change":-5.84,"latestTime":"05-02 04:32:55 EDT","open":159,"high":164.15,"low":151.82,"amount":143876733.08816,"amplitude":0.075091,"askPrice":170,"askSize":1,"bidPrice":153.2,"bidSize":4,"shortable":3,"etf":0,"ttmEps":0.74,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714656600000},"adr":0,"adjPreClose":158.36,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":158.36,"preClose":158.36,"latestTime":"19:33 EDT","volume":19623,"amount":3107500.44,"timestamp":1714606410226},"volumeRatio":1.969159904499707},"requestUrl":"/m/hq/s/RGEN/","defaultTab":"news","newsList":[{"id":"2432570203","title":"Repligen 公司公布截至三月份的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2432570203","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432570203?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:52","pubTimestamp":1714571577,"startTime":"0","endTime":"0","summary":"   * Repligen Corp   公布的截至三月份的季度调整后每股收益为28美分，低于去年同期的每股收益64美分。12 位分析师对该季度的平均预期是每股收益 30 美分。华尔街预期为每股收益 27 美分至 34 美分。* Repligen 公司公布的本季度每股收益为 4 美分。* 公司报告的季度净收入为 209 万美元。* Repligen Corp本季度股价下跌了10.7%，今年迄今为止下跌了8.7%。华尔街对 Repligen 公司 12 个月目标价的中位数为 215.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432770105","title":"Repligen Corporation盘中异动 早盘快速下跌6.18%报154.06美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432770105","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432770105?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:31","pubTimestamp":1714570282,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时31分，Repligen Corporation股票出现异动，股价大幅下挫6.18%。截至发稿，该股报154.06美元/股，成交量3.2838万股，换手率0.06%，振幅4.87%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.35%。其相关个股中，Predictive Oncology Inc.、Milestone Scientific, Inc.、Singular Genomics Systems, Inc.涨幅较大，Predictive Oncology Inc.、Repligen Corporation、Atrion较为活跃，换手率分别为76.81%、0.06%、0.05%，振幅较大的相关个股有Glucotrack, Inc.、Predictive Oncology Inc.、Repligen Corporation，振幅分别为7.79%、6.26%、4.87%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012131237a57db31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012131237a57db31&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431489912","title":"Repligen Corp    预计每股收益 30 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2431489912","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431489912?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:33","pubTimestamp":1714404798,"startTime":"0","endTime":"0","summary":"   * Repligen公司   将于5月1日公布截至2024年3月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，12位分析师的平均预期显示，这家总部位于马萨诸塞州沃尔瑟姆市的公司的营收将从去年同期的1.8266亿美元降至1.5062亿美元，降幅为17.8%。* LSEG分析师对Repligen公司的平均预期为每股收益30美分。* 华尔街对 Repligen Corp 的 12 个月目标价中位数为 215.00 美元，高于其上次收盘价 166.58 美元。4月29日 - 上一季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2429190453","title":"Repligen Corporation盘中异动 急速拉升5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429190453","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429190453?lang=zh_cn&edition=full","pubTime":"2024-04-23 21:31","pubTimestamp":1713879078,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日21时31分，Repligen Corporation股票出现异动，股价急速上涨5.44%。截至发稿，该股报166.05美元/股，成交量1.9061万股，换手率0.03%，振幅0.58%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.35%。其相关个股中，Repligen Corporation、Glucotrack, Inc.、AtriCure涨幅较大，Glucotrack, Inc.、Predictive Oncology Inc.、Microbot Medical Inc.较为活跃，换手率分别为0.10%、0.06%、0.06%，振幅较大的相关个股有AtriCure、Repligen Corporation、Staar Surgical Company，振幅分别为1.76%、1.53%、1.35%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232131188b4abe56&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232131188b4abe56&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428359101","title":"Repligen Corporation盘中异动 早盘大幅跳水5.43%报152.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428359101","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428359101?lang=zh_cn&edition=full","pubTime":"2024-04-18 21:31","pubTimestamp":1713447102,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日21时31分，Repligen Corporation股票出现异动，股价快速下挫5.43%。截至发稿，该股报152.24美元/股，成交量6.7003万股，换手率0.12%，振幅1.31%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.11%。其相关个股中，中进医疗、Nephros, Inc.、瑞思迈涨幅较大，Predictive Oncology Inc.、Repligen Corporation、Bionano Genomics, Inc.较为活跃，换手率分别为0.46%、0.12%、0.09%，振幅较大的相关个股有Bionano Genomics, Inc.、中进医疗、Repligen Corporation，振幅分别为4.90%、4.67%、1.83%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418213142861e7108&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418213142861e7108&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421075928","title":"Repligen Corporation涨1.67% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2421075928","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421075928?lang=zh_cn&edition=full","pubTime":"2024-03-22 03:12","pubTimestamp":1711048354,"startTime":"0","endTime":"0","summary":"北京时间2024年03月22日03时12分，Repligen Corporation股票出现异动，股价急速上涨1.67%。截至发稿，该股报200.00美元/股，成交量13.4558万股，换手率0.24%，振幅1.68%。Repligen Corporation股票所在的医疗设备行业中，整体涨幅为0.97%。其相关个股中，Innovative Eyewear Inc C/Wts 16/08/2027  Ser A、美华国际、Nyxoah Sa涨幅较大，Sharps Technology Inc.、Femasys Inc.、Avinger, Inc.较为活跃，换手率分别为9.90%、3.90%、3.31%，振幅较大的相关个股有中进医疗、Innovative Eyewear Inc C/Wts 16/08/2027  Ser A、Innovative Eyewear, Inc.，振幅分别为36.76%、21.29%、17.21%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322031235861e02cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240322031235861e02cf&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2417866057","title":"Repligen Corporation涨1.28% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2417866057","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2417866057?lang=zh_cn&edition=full","pubTime":"2024-03-08 22:31","pubTimestamp":1709908305,"startTime":"0","endTime":"0","summary":"北京时间2024年03月08日22时31分，Repligen Corporation股票出现异动，股价快速上涨1.28%。截至发稿，该股报201.00美元/股，成交量1.0032万股，换手率0.02%，振幅1.06%。Repligen Corporation股票所在的医疗设备行业中，整体跌幅为0.11%。其相关个股中，Predictive Oncology Inc.、Staar Surgical Company、Daxor Corporation涨幅较大，Avinger, Inc.、Predictive Oncology Inc.、Femasys Inc.较为活跃，换手率分别为2.69%、0.16%、0.15%，振幅较大的相关个股有Femasys Inc.、泰利福、Retractable Technologies, Inc.，振幅分别为2.95%、2.00%、1.64%。Repligen Corporation公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822314687e774fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030822314687e774fd&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2414247701","title":"Repligen Corp2023财年实现净利润41.58百万美元，同比减少77.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2414247701","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2414247701?lang=zh_cn&edition=full","pubTime":"2024-02-25 00:21","pubTimestamp":1708791670,"startTime":"0","endTime":"0","summary":"12月31日，Repligen Corp公布财报，公告显示公司2023财年净利润为41.58百万美元，同比减少77.65%；其中营业收入为6.39亿美元，同比减少20.32%，每股基本收益为0.75美元。从资产负债表来看，Repligen Corp总负债8.53亿美元，其中短期债务75.08百万美元，资产负债比为3.32，流动比率为7.04。机构评级：截至2023年12月31日，当前有12家机构对Repligen Corp目标价做出预测，其中目标均价为206.65美元，其中最低目标价为160.00美元，最高目标价为230.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022500211281b3133e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022500211281b3133e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2413420708","title":"嗡嗡声--美国股票走势-Toll Brothers、Natgas 公司、Eton 制药公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2413420708","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413420708?lang=zh_cn&edition=full","pubTime":"2024-02-21 23:55","pubTimestamp":1708530942,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      2月21日 - 华尔街周三下跌，因为投资者在等待芯片设计公司英伟达的高风险财报，如果财报不尽如人意，可能会阻碍今年的人工智能热潮。美东时间10:33，道琼斯工业平均指数  下跌0.24%，报38472.83点。标准普尔500指数  下跌0.26%，报4,962.55点；纳斯达克综合指数  下跌0.62%，报15,533.91点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413425777","title":"BUZZ-Repligen因年度业绩预期不佳而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2413425777","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2413425777?lang=zh_cn&edition=full","pubTime":"2024-02-21 22:11","pubTimestamp":1708524714,"startTime":"0","endTime":"0","summary":"    2月21日 - ** 为生物制药公司生产产品的Repligen   股价盘前下跌6.9%至186美元** 该公司预计24财年营收在6.2亿至6.5亿美元之间，低于华尔街预期的6.607亿美元--LSEG数据 ** 公司预计24财年每股收益在1.42-1.49美元之间，低于分析师预期的1.77美元。** 第四季度营收从去年同期的 1.868 亿美元降至 1.557 亿美元** Repligen公司第四季度亏损2550万美元，去年同期盈利4870万美元。** 13家券商中有10家将该股评为 \"买入 \"或更高评级，3家为 \"持有\"；其PT中值为192.50美元** 2023 年，RGEN 股价上涨 6.2","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2413107725","title":"Repligen Corp跌4.14% 股价跌破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2413107725","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2413107725?lang=zh_cn&edition=full","pubTime":"2024-02-21 00:38","pubTimestamp":1708447105,"startTime":"0","endTime":"0","summary":"北京时间2024年02月21日00时38分，Repligen Corp股票出现波动，股价急速下跌4.14%。截至发稿，该股报199.80美元/股，成交量30.3549万股，换手率0.54%，振幅3.54%。Repligen Corp股票所在的医疗设备行业中，整体跌幅为0.05%。Repligen Corp公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402210038257912ca7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402210038257912ca7a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2412139394","title":"Repligen Corp    预计每股收益 33 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2412139394","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2412139394?lang=zh_cn&edition=full","pubTime":"2024-02-19 22:17","pubTimestamp":1708352277,"startTime":"0","endTime":"0","summary":"   * Repligen公司   将于2月21日公布截至2023年12月31日的财报，预计该公司的季度收入将出现下降。* 根据LSEG的数据，11位分析师的平均预期显示，这家总部位于美国马萨诸塞州沃尔瑟姆市的公司的营收将从去年同期的1.8676亿美元降至1.5538亿美元，降幅为16.8%。* LSEG分析师对Repligen公司的平均预期为每股收益33美分。* 华尔街对 Repligen Corp 的 12 个月目标价中位数为 196.40 美元，低于其上次收盘价 208.42 美元。2月19日 - 以前季度业绩。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2411028843","title":"Repligen Corp涨1.77% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2411028843","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2411028843?lang=zh_cn&edition=full","pubTime":"2024-02-14 22:32","pubTimestamp":1707921135,"startTime":"0","endTime":"0","summary":"北京时间2024年02月14日22时32分，Repligen Corp股票出现波动，股价快速拉升1.77%。截至发稿，该股报201.98美元/股，成交量3060股，换手率0.01%，振幅0.00%。Repligen Corp股票所在的医疗设备行业中，整体涨幅为0.18%。其相关个股中，Femasys Inc、Bionano Genomics Inc、Nyxoah Sa涨幅较大，Bionano Genomics Inc、Femasys Inc、Avinger Inc较为活跃，换手率分别为0.30%、0.10%、0.08%，振幅较大的相关个股有Bionano Genomics Inc、Zentek Ltd、Femasys Inc，振幅分别为5.03%、3.15%、2.61%。Repligen Corp公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214223215818c1a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240214223215818c1a04&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2409280355","title":"Repligen Corp涨2.00% 股价突破200美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2409280355","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2409280355?lang=zh_cn&edition=full","pubTime":"2024-02-07 02:45","pubTimestamp":1707245131,"startTime":"0","endTime":"0","summary":"北京时间2024年02月07日02时45分，Repligen Corp股票出现异动，股价大幅拉升2.00%。截至发稿，该股报200.02美元/股，成交量15.1128万股，换手率0.27%，振幅1.90%。Repligen Corp股票所在的医疗设备行业中，整体涨幅为1.27%。其相关个股中，Sharps Technology Inc C/Wts 13/04/2027 、ICU医疗、Staar Surgical Co涨幅较大，Nanostring Technologies Inc、Sharps Technology Inc、Staar Surgical Co较为活跃，换手率分别为85.05%、2.65%、1.93%，振幅较大的相关个股有Sharps Technology Inc C/Wts 13/04/2027 、Nanostring Technologies Inc、Sharps Technology Inc，振幅分别为97.60%、33.14%、17.34%。Repligen Corp公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240207024531861d3655&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240207024531861d3655&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2406999377","title":"Repligen Corp盘中异动 大幅拉升5.02%报194.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2406999377","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2406999377?lang=zh_cn&edition=full","pubTime":"2024-01-26 22:30","pubTimestamp":1706279432,"startTime":"0","endTime":"0","summary":"北京时间2024年01月26日22时30分，Repligen Corp股票出现异动，股价快速拉升5.02%。截至发稿，该股报194.83美元/股，成交量2.2614万股，换手率0.04%，振幅0.00%。Repligen Corp股票所在的医疗设备行业中，整体涨幅为0.00%。其相关个股中，Nyxoah Sa、Repligen Corp、Ekso Bionics Holdings Inc涨幅较大，Bionano Genomics Inc、Femasys Inc、Nyxoah Sa较为活跃，换手率分别为0.23%、0.10%、0.06%，振幅较大的相关个股有Nephros Inc、Bausch Plus Lomb Corp、Retractable Technologies Inc，振幅分别为0.84%、0.83%、0.81%。Repligen Corp公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012622303287e68fd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024012622303287e68fd0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2391599166","title":"Repligen Corp盘中异动 股价大涨5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2391599166","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2391599166?lang=zh_cn&edition=full","pubTime":"2023-12-14 03:39","pubTimestamp":1702496358,"startTime":"0","endTime":"0","summary":"北京时间2023年12月14日03时39分，Repligen Corp股票出现异动，股价大幅上涨5.07%。截至发稿，该股报171.21美元/股，成交量44.9836万股，换手率0.81%，振幅5.25%。Repligen Corp股票所在的医疗设备行业中，整体涨幅为1.96%。其相关个股中，美华国际、Nephros Inc、Pulse Biosciences Inc涨幅较大，Femasys Inc、Innovative Eyewear Inc、Envista Holdings Corporation较为活跃，换手率分别为2.22%、1.99%、1.79%，振幅较大的相关个股有美华国际、Nephros Inc、Ekso Bionics Holdings Inc，振幅分别为20.57%、16.73%、15.38%。Repligen Corp公司简介：Repligen Corp是一家全球性的生命科学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121403391884767339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121403391884767339&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.repligen.com","stockEarnings":[{"period":"1week","weight":-0.0566},{"period":"1month","weight":-0.1344},{"period":"3month","weight":-0.1782},{"period":"6month","weight":0.0532},{"period":"1year","weight":0.0072},{"period":"ytd","weight":-0.1192}],"compareEarnings":[{"period":"1week","weight":-0.01},{"period":"1month","weight":-0.0418},{"period":"3month","weight":0.0228},{"period":"6month","weight":0.1511},{"period":"1year","weight":0.2179},{"period":"ytd","weight":0.0527}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Repligen Corporation是供应生物制药关键产品的领军者。公司生产的蛋白质A为重要生命科学研究公司提供长期供应、长期合约，并同时直接向制药加工链终端使用者销售。公司向SecreFlo公司最新的药物提供专业生物研发产品，这种药物已经向美国食品药品行政管理局递交申请并已获得优先检验，公司已向欧洲药物管理机构递交了市场授权许可。SecreFlo是研发诊断胰腺炎和多种潜在胰腺疾病的合成人类激素药物新型显像剂的企业。公司进行两个早期中枢神经系统罕见疾病项目研究，弗里德里希运动失调和脊柱肌肉萎缩进入到了临床试验的第一阶段。此外，公司已从Bristol-Myers Squibb公司获得知识产权的额外许可——该公司可在美国对药物阿巴西普实价销售的专利权。公司于1981年5月成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.684211,"avgChangeRate":0.094555},{"month":2,"riseRate":0.421053,"avgChangeRate":0.031694},{"month":3,"riseRate":0.552632,"avgChangeRate":0.040702},{"month":4,"riseRate":0.473684,"avgChangeRate":-0.005601},{"month":5,"riseRate":0.564103,"avgChangeRate":0.052176},{"month":6,"riseRate":0.473684,"avgChangeRate":-0.009081},{"month":7,"riseRate":0.5,"avgChangeRate":0.023766},{"month":8,"riseRate":0.578947,"avgChangeRate":0.03293},{"month":9,"riseRate":0.368421,"avgChangeRate":-0.040492},{"month":10,"riseRate":0.473684,"avgChangeRate":0.026608},{"month":11,"riseRate":0.447368,"avgChangeRate":0.027598},{"month":12,"riseRate":0.5,"avgChangeRate":-0.001659}],"exchange":"NASDAQ","name":"Repligen Corporation","nameEN":"Repligen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Repligen Corporation,RGEN,Repligen Corporation股票,Repligen Corporation股票老虎,Repligen Corporation股票老虎国际,Repligen Corporation行情,Repligen Corporation股票行情,Repligen Corporation股价,Repligen Corporation股市,Repligen Corporation股票价格,Repligen Corporation股票交易,Repligen Corporation股票购买,Repligen Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Repligen Corporation(RGEN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Repligen Corporation(RGEN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}